Melanoma March has officially launched
5 February 2015
Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.
The launch event held at Tonic House in Melbourne’s CBD revealed plans for the new funding. There will be 23 marches that are happening around Australia, with the first march kicking off in Melbourne on the 22nd February.
Professor Graham Mann, Research Director at MIA, explained how the Melanoma March campaign provides critical funding for our expert clinicians to get one step closer to finding a cure. He revealed the beneficiary of the 2015 initiative will be the next phase of the Melanoma Genome Project.
“Monies raised from last year’s Melanoma March campaign contributed to the world-first PD-1 Brain Metastases Trial - that is currently underway,” he said.
“Half of all patients diagnosed with stage 4 melanoma will develop brain metastases at some point during their illness. Until now, treatment has been unavailable and as such the clinicians at Melanoma Institute Australia are committed to developing new treatment options that provide potential hope to patients with brain metastases and could prove to be a significant step in finding a cure.
“Funds raised from the 2015 Melanoma March campaign will enable Melanoma Institute Australia and melanoma research centres around the nation to work together to launch a study which hopes to enable melanoma cells to be isolated, banked, distributed and tested against new treatments. This approach is a powerful way to capitalise on new knowledge from gene and immunity analysis that is showing where melanoma is vulnerable to attack.
Known as ‘Australia’s national cancer’, Australia has the highest incidence of melanoma in the world with over 12,500 new cases diagnosed each year, equating to one person dying every six hours from melanoma in Australia. Sadly, melanoma kills more young Australians (15-39 year-olds) than any other single cancer, proving why continual funding for research is key in addressing this devastating illness.
The Melbourne launch was also attended by former AFL icon and melanoma survivor, Tim McGrath as well as award winning musician Bob Corbett and channel Ten news presenter Brad McEwen.
To see where your local march is and how you can get involved to help us raise $1 million for melanoma research click here.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.